The Food Safety and Standards Authority of India (FSSAI) has initiated regulatory action against major food companies, including Nestle and Zydus Wellness, regarding the marketing claims made on their products. The regulator is specifically scrutinizing advertisements that suggest health and developmental benefits for children.

In the case of Zydus Wellness, the FSSAI has requested documentation to substantiate the claim that their product, Complan, promotes '2 times faster growth' in children. This move is part of a broader effort by the Indian food safety watchdog to ensure that nutritional claims made by manufacturers are backed by verifiable scientific data rather than just marketing rhetoric.

While the FSSAI has confirmed the issuance of these notices, the companies involved have not yet released detailed public responses regarding the specific evidence they intend to provide. The regulatory inquiry highlights a growing trend of increased oversight in the Indian food and beverage sector, particularly concerning products marketed toward infants and growing children. The FSSAI's intervention aims to prevent potentially misleading health claims that could influence consumer purchasing decisions based on unverified developmental promises. As of now, the investigation remains in the information-gathering stage, with the regulator awaiting formal submissions from the companies to justify their product labeling and advertising strategies.